Prajakt Life Science Profile
Key Indicators
- Authorised Capital ₹ 5.00 M
as on 16-11-2024
- Paid Up Capital ₹ 5.00 M
as on 16-11-2024
- Company Age 5 Year, 22 Days
- Last Filing with ROC 31 Mar 2024
- Open Charges ₹ 2.70 Cr
as on 16-11-2024
- Revenue 17.51%
(FY 2023)
- Profit 16.34%
(FY 2023)
- Ebitda 30.82%
(FY 2023)
- Net Worth 25.80%
(FY 2023)
- Total Assets 15.99%
(FY 2023)
About Prajakt Life Science
The Company is engaged in the Life Sciences Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2024. It's a company limited by shares with an authorized capital of Rs 5.00 M and a paid-up capital of Rs 5.00 M.
The company currently has active open charges totaling ₹2.70 Cr.
Anurag Sarawagi and Anjana Sarawagi serve as directors at the Company.
- CIN/LLPIN
U24299GJ2019PTC111200
- Company No.
111200
- Company Classification
Private Limited Indian Non-Government Company
- Incorporation Date
04 Dec 2019
- Date of AGM
30 Sep 2024
- Date of Balance Sheet
31 Mar 2024
- Listing Status
Unlisted
- ROC Code
Roc Ahmedabad
Industry
Company Details
- Location
Surat, Gujarat, India
- Telephone
- Email Address
- Website
- Social Media
Who are the key members and board of directors at Prajakt Life Science?
Board Members(2)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Anurag Sarawagi  | Director | 04-Dec-2019 | Current |
| Anjana Sarawagi | Director | 04-Dec-2019 | Current |
Financial Performance of Prajakt Life Science.
Prajakt Life Science Private Limited, for the financial year ended 2023, experienced significant growth in revenue, with a 17.51% increase. The company also saw a substantial improvement in profitability, with a 16.34% increase in profit. The company's net worth Soared by an impressive increase of 25.8%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metric |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
| ||||||
| Revenue from Operations |
| ||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of Prajakt Life Science?
In 2023, Prajakt Life Science had a promoter holding of 100.00%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Related Corporates (Common Directorship)
Deendayal & Modoom Industries Private LimitedActive 6 years 3 monthsAnurag Sarawagi is a mutual person
- Prajakt Agro Industries Private LimitedActive 9 months 19 days
Anurag Sarawagi and Anjana Sarawagi are mutual person
- Taashi Gems & Jewellers Private LimitedInactive For E-Filing 7 months 13 days
Anurag Sarawagi is a mutual person
Charges (Loans)
| Lender | Amount | Status |
|---|---|---|
City Union Bank Limited Creation Date: 17 Dec 2020 | ₹2.70 Cr | Open |
How Many Employees Work at Prajakt Life Science?
Unlock and access historical data on people associated with Prajakt Life Science, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Prajakt Life Science, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Prajakt Life Science's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
